Peptide stacks · Healing and repair · also called BPC-157 + TB-500
Wolverine stack: what’s in it and the evidence
Checked against our library and study pagesPublished by PepVault
The Wolverine stack is a blend of two compounds, BPC-157 and TB-500, that the peptide community runs for repair and recovery. It isn’t one vial: the amounts the library records per dose are 250–500 mcg of BPC-157 and 1.5–2 mg of TB-500.
This page describes what the crowd runs and what a vial holds. It recommends no stack and names no seller.
What’s in the Wolverine stack
| Part | Amount | What it’s there for | Evidence (library) |
|---|---|---|---|
| BPC-157 | 250–500 mcg | Tendon, ligament, muscle & gut repair | Emerging |
| TB-500 | 1.5–2 mg | Cell migration & wound repair in cell and rodent studies | Emerging |
The amount per dose the library records, part by part
BPC-157
In the Wolverine stack, BPC-157 is listed for “Tendon, ligament, muscle & gut repair”. A peptide derived from a protective protein in the stomach.
TB-500
In the Wolverine stack, TB-500 is listed for “Cell migration & wound repair in cell and rodent studies”. A fragment of thymosin beta-4, a protein the body uses for cell repair.

Has the Wolverine stack been studied as a combination?
1 study page of ours tested BPC-157 and TB-500 together:
What the library says about the evidence for the Wolverine stack
No published study has tested BPC-157 and TB-500 in combination in humans. The popular pairing rests on complementary actions (BPC-157's growth-factor/angiogenic actions plus TB-500's actin-mediated cell migration), but the one controlled test, a 2026 study of Achilles tendon repair in 32 rats, found the pair did no better than either peptide alone. In the one rat study of the pair, each helped the tendon heal and TB-500 made it stronger; combining them didn't add more there. Biçer 2026 is the only controlled test of the two together: in 32 rats with cut and repaired Achilles tendons, TB-500 alone significantly raised the load the tendons took before failing and improved their tissue scores, BPC-157 alone trended the same way without reaching significance, and the combination added nothing over either peptide alone.
The studies of the parts, one by one: 14 study pages on BPC-157 (2 in people) and 9 study pages on TB-500 (2 in people).
| Part | Study pages | In people | Strongest study page |
|---|---|---|---|
| BPC-157 | 14 | 2 | BPC-157: 10 of 12 women reported full interstitial cystitis relief (clinical trial, 2024) |
| TB-500 | 9 | 2 | Thymosin beta-4: no overall infarct area cut in 96 STEMI patients (randomized trial, 2025) |
What people commonly report on the Wolverine stack
Commonly reported: faster recovery from tendon and ligament injuries. Faster recovery from tendon and ligament injuries, with stiffness easing in the first couple of weeks and load tolerance improving after that.
These are reports from people who run it, collected in the library, not results from a trial and not a promise of what any one person will notice.
Why these are combined
The library gives two reasons for combining the parts of the Wolverine stack:
- Local plus body-wide coverage: BPC-157 works at the injury site (new blood vessels, tendon and ligament repair) while TB-500 helps repair cells move in. Each role comes from its own research, mostly in animals.
- In rat studies BPC-157 protected the gut against NSAID damage, part of why athletes who lean on painkillers pair it with TB-500 for the musculoskeletal side.
From the library’s notes on the Wolverine stack
The most classic healing stack in the peptide community. The two work in complementary ways — BPC-157 more at the injury site, TB-500 body-wide. Often called the "healing duo".
“BPC-157 + TB-500 hit two different arms of healing”, the library’s note on the pair (community report)
The most popular healing pair runs on a simple split: BPC-157 builds new blood supply at the injury while TB-500 helps repair cells move in.
“The classic healing combo”, the BPC-157 entry’s note (community report)
A community favorite built on a simple split: BPC-157 works on local repair, new blood supply and tendon healing, while TB-500 helps repair cells move in. Two different jobs toward the same repair. BPC-157's case is rat work on blood supply and tendon healing; TB-500's is lab and animal work on cell migration, much of it done with the whole thymosin beta-4 protein.
“The classic healing combo”, the TB-500 entry’s note (community report)
The pair is popular because each covers a different part of repair: TB-500 helps repair cells move into damaged tissue, while BPC-157 works on local tendon and gut repair. Biçer 2026: 32 rats had an Achilles tendon cut and repaired, then 4 weeks of daily treatment injected into the abdominal cavity, in groups of 8: none, BPC-157, TB-500, or both. The authors suggest the two may converge on shared downstream pathways, which is untested. Before this study, the pairing rested only on mechanisms from separate studies.
How the parts of the Wolverine stack are mixed and taken
The Wolverine stack isn’t one pre-mixed vial in the library: each part has its own route and schedule, as its entry records them.
| Part | Route | How often | Our vial pages |
|---|---|---|---|
| BPC-157 | SubQ injection, IM injection, Oral (less studied) | Once or twice daily | 5 mg vial, 10 mg vial |
| TB-500 | SubQ injection, IM injection | 2x/week loading, 1–2mg/week maintenance | 5 mg vial, 10 mg vial |
Our vial pages work out the mix for each part’s own vial, size by size:
Compared with running the parts apart
What the library says about the Wolverine stack against its parts on their own:
- TB-500 alone significantly raised the load the tendons took before failing and improved their tissue scores; BPC-157 alone trended the same way without reaching significance; the combination added nothing over either alone.
Safety notes
The library’s combination safety note on the Wolverine stack
FDA (April 2026) says it has found no human exposure data for TB-500 and little or no safety data for BPC-157; it also flags a possible risk of immune reactions to compounded BPC-157 and TB-500. Because both are proangiogenic, the literature flags a theoretical concern in anyone who may harbor an undiagnosed malignancy, since angiogenesis supports tumor growth.
The TB-500 interaction note
When stacked with other healing peptides (e.g. BPC-157) the combined proangiogenic effect is a theoretical consideration worth raising with a clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Questions people ask
What is in the Wolverine stack?
The Wolverine stack is a blend of two compounds, BPC-157 and TB-500, that the peptide community runs for repair and recovery. It isn’t one vial: the amounts the library records per dose are 250–500 mcg of BPC-157 and 1.5–2 mg of TB-500.
Has the Wolverine stack been studied together?
Yes: 1 study page of ours tested BPC-157 and TB-500 together, starting with “BPC-157: non-significant tendon gains in rats; TB-500 did better”.
What do people report on the Wolverine stack?
Commonly reported: faster recovery from tendon and ligament injuries. These are reports from people who run it.
Do the parts of the Wolverine stack come in one vial?
No: in the library each part of the Wolverine stack is its own compound with its own route and schedule (BPC-157 by SubQ injection and TB-500 by SubQ injection).
What does each part of the Wolverine stack do?
The library lists BPC-157 for “Tendon, ligament, muscle & gut repair” and TB-500 for “Cell migration & wound repair in cell and rodent studies”.
How does the Wolverine stack compare with taking the parts separately?
From the library: TB-500 alone significantly raised the load the tendons took before failing and improved their tissue scores; BPC-157 alone trended the same way without reaching significance; the combination added nothing over either alone.